THOUSAND OAKS, Calif., March 30 /PRNewswire-FirstCall/ -- Amgen will present at Citigroup's 4th Annual Biotech Day on Wednesday, April 1, 2009 at the Citigroup Conference Center, New York, N.Y., beginning at 11:20 a.m. Eastern Time. Amgen Vice President of Investor Relations Arvind Sood will present. Live audio of the presentation will be available over the Internet and can be accessed from Amgen's Web site, http://www.amgen.com/, under Investors.
Information regarding presentation time, webcast availability, and webcast links are available on Amgen's Investor Relations Events Calendar.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit http://www.amgen.com/.
CONTACT: Amgen, Thousand Oaks David Polk, 805-447-4613 (media) Justin Claeys, 805-447-1060 (investors) (Logo: http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)
http://photoarchive.ap.org/
PRN Photo Desk, photodesk@prnewswire.com
Amgen
CONTACT: media, David Polk, +1-805-447-4613, or investors, Justin
Claeys, +1-805-447-1060, both of Amgen, Thousand Oaks
Web Site: http://www.amgen.com/
